ArticleTrialsPublished
Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial
Regional connection
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, Perelman School of Medicine, with Drexel University, University of Pennsylvania linked by the institution reference. Affiliation source
Publication record
- Type
- Article
- Venue
- Trials
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Arthritis, Psoriatic; Tumor Necrosis Factor-alpha; Antirheumatic Agents; Antibodies, Monoclonal; Treatment Outcome; Longitudinal Studies; Prospective Studies; Time Factors; Multicenter Studies as Topic; Clinical Trials, Phase III as Topic; Drug Substitution
- PubMed ID
- 40102973
- PubMed Central ID
- PMC11921613
- Open access
- Yes, open
- Added to directory
- Source checked